ATE230270T1 - Puderpräparat zur heilung verletzter haut - Google Patents

Puderpräparat zur heilung verletzter haut

Info

Publication number
ATE230270T1
ATE230270T1 AT95108920T AT95108920T ATE230270T1 AT E230270 T1 ATE230270 T1 AT E230270T1 AT 95108920 T AT95108920 T AT 95108920T AT 95108920 T AT95108920 T AT 95108920T AT E230270 T1 ATE230270 T1 AT E230270T1
Authority
AT
Austria
Prior art keywords
powder preparation
salts
injured skin
healing
healing injured
Prior art date
Application number
AT95108920T
Other languages
English (en)
Inventor
Toshio Inagi
Saibi Suehiro
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE230270T1 publication Critical patent/ATE230270T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT95108920T 1994-06-27 1995-06-09 Puderpräparat zur heilung verletzter haut ATE230270T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14439394A JP3583166B2 (ja) 1994-06-27 1994-06-27 損傷皮膚修復用粉末製剤

Publications (1)

Publication Number Publication Date
ATE230270T1 true ATE230270T1 (de) 2003-01-15

Family

ID=15361113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95108920T ATE230270T1 (de) 1994-06-27 1995-06-09 Puderpräparat zur heilung verletzter haut

Country Status (12)

Country Link
US (1) US5618799A (de)
EP (1) EP0689841B1 (de)
JP (1) JP3583166B2 (de)
KR (1) KR100370313B1 (de)
CN (1) CN1059088C (de)
AT (1) ATE230270T1 (de)
CA (1) CA2150888A1 (de)
DE (1) DE69529249T2 (de)
DK (1) DK0689841T3 (de)
ES (1) ES2189811T3 (de)
SI (1) SI0689841T1 (de)
TW (1) TW336173B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU722246B2 (en) * 1995-06-07 2000-07-27 Johnson & Johnson Consumer Products, Inc. Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same
US6562885B1 (en) 1998-03-19 2003-05-13 Battelle Memorial Institute Composition for deactivating chemically and biologically active agents and method of making the same
JP2002518351A (ja) 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6414223B1 (en) * 1998-08-03 2002-07-02 Cargill, Incorporated Plants, seeds and oils having an elevated total monounsaturated fatty acid content
NZ513711A (en) 1999-02-26 2004-01-30 Warner Lambert Co Bioadhesive antibacterial wound healing composition
RU2181050C2 (ru) * 1999-05-21 2002-04-10 Плотников Владимир Михайлович Противоопухолевая и антибактериальная композиция
JP2001122790A (ja) * 1999-10-22 2001-05-08 Mikasa Seiyaku Co Ltd 安定な褥瘡・皮膚潰瘍および創傷治療用製剤
DE60327752D1 (de) 2002-03-14 2009-07-09 Medrx Co Ltd Topisches medikament für wunden
WO2004011032A1 (ja) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. 外用剤
WO2004043473A1 (ja) * 2002-11-11 2004-05-27 Kowa Co., Ltd. 損傷皮膚修復用組成物
US20040101507A1 (en) * 2002-11-27 2004-05-27 Janco Predovan Skin cream
WO2004056339A1 (de) * 2002-12-19 2004-07-08 Beisel Guenther Verfahren zur herstellung von mitteln zur oralen einnahme und entsprechende zusammensetzungen unter verwendung von polymeren und deren beschichtung mit hydrophilen flüssigkeiten
RU2245723C1 (ru) * 2003-07-24 2005-02-10 Вилесов Александр Дмитриевич Средство и способ лечения гнойно-воспалительных заболеваний мягких тканей
WO2005027940A1 (ja) * 2003-09-22 2005-03-31 Kowa Co., Ltd. 損傷皮膚修復用貼付剤
US7673841B2 (en) 2004-03-25 2010-03-09 Cooper Technologies Company Hangar bar for recessed luminaires with integral nail
JP4575705B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
JP4575706B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
US7334538B1 (en) * 2004-07-27 2008-02-26 Aquascience Research Group, Inc. Topical medicants for aquatic animals
CN1279917C (zh) * 2004-09-09 2006-10-18 吕益明 一种创伤药及其制备方法和使用方法
CA2607419C (en) 2005-04-26 2014-06-17 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation containing biguanide compound
NZ542258A (en) * 2005-09-06 2010-05-28 Comvita New Zealand Ltd A medical composition comprising honey or sugar syrup and a viscosity increasing agent for use on wounds
US8664295B2 (en) * 2005-10-28 2014-03-04 Nutripol Capital Sarl Polymeric compound, method of preparing a polymeric compound, use of a polymeric compound
JP5315056B2 (ja) 2006-10-25 2013-10-16 大日本住友製薬株式会社 固結抑制粒状製剤
US20100280064A1 (en) * 2006-12-07 2010-11-04 Tomoyuki Watanabe Pharmaceutical composition having improved storage stability
EP2100606A4 (de) * 2006-12-07 2009-12-30 Daiichi Sankyo Co Ltd Zubereitung mit filmüberzug und verbesserter stabilität
CA2672134C (en) * 2006-12-07 2015-02-10 Daiichi Sankyo Company, Limited Solid medicinal preparation containing mannitol or lactose
TWI482641B (zh) 2006-12-07 2015-05-01 Daiichi Sankyo Co Ltd 含有低取代度羥丙基纖維素之醫藥組成物
CA2738136A1 (en) * 2008-09-22 2010-03-25 Triosyn Holding, Inc. A novel iodinated resin manufacturing process and product
CN101654499B (zh) * 2009-09-02 2011-08-31 陈煜� 天然高分子或其水溶性衍生物的两亲性接枝共聚物与纳米碘复合物及其制备方法
CN102846776B (zh) * 2012-09-28 2015-02-11 刘艳 一种由桃树末制成的药剂
JP2018500312A (ja) * 2014-12-30 2018-01-11 スリーエム イノベイティブ プロパティズ カンパニー 消毒組成物
KR20190032629A (ko) * 2015-01-20 2019-03-27 벨로체 바이오파르마 엘엘씨 신규한 요오드포 조성물 및 사용 방법
FR3099032B1 (fr) * 2019-07-26 2021-07-30 Oreal Article cosmétique
AU2022277569A1 (en) * 2021-05-18 2023-12-14 Povinez Llc Nasal antiseptic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353297A1 (fr) * 1976-01-26 1977-12-30 Tissier Gerard Nouveaux complexes neutres et insolubles de la polyvinylpolypyrrolidone et des halogenes, leurs procedes d'obtention et leurs applications
US4094967A (en) * 1976-10-22 1978-06-13 Allor Foundation Iodine-polyvinylpyrrolidone solid product and method of preparation
AU536885B2 (en) * 1979-04-18 1984-05-31 R. A. Knutson Wound and burn dressing
DE3312431A1 (de) * 1983-04-07 1984-10-11 B. Braun Melsungen Ag, 3508 Melsungen Pvp-iod-wundpuder mit synergistisch wirkender pudergrundlage
NL8500774A (nl) * 1985-03-18 1986-10-16 Dagra Nv Werkwijze ter bereiding van een vrij vloeiend, homogeen povidonjood wondpoeder.
CA1287584C (en) * 1986-09-02 1991-08-13 Seiichi Komori Wound-healing preparations
GB8622012D0 (en) * 1986-09-12 1986-10-22 Euro Celtique Sa Solid iodophor composition
CH678697A5 (de) * 1989-04-03 1991-10-31 Warner Lambert Co
US4877927A (en) * 1989-04-06 1989-10-31 Hamlin Incorporated Extended dwell shock sensing device

Also Published As

Publication number Publication date
SI0689841T1 (en) 2003-04-30
KR100370313B1 (ko) 2003-03-19
EP0689841B1 (de) 2003-01-02
CN1059088C (zh) 2000-12-06
ES2189811T3 (es) 2003-07-16
DE69529249T2 (de) 2003-08-07
JP3583166B2 (ja) 2004-10-27
KR960000214A (ko) 1996-01-25
TW336173B (en) 1998-07-11
US5618799A (en) 1997-04-08
EP0689841A1 (de) 1996-01-03
DE69529249D1 (de) 2003-02-06
CA2150888A1 (en) 1995-12-28
DK0689841T3 (da) 2003-02-24
CN1124143A (zh) 1996-06-12
JPH0812582A (ja) 1996-01-16

Similar Documents

Publication Publication Date Title
DE69529249D1 (de) Puderpräparat zur Heilung verletzter Haut
EP0366101A3 (de) Verfahren zum Ueberdecken des Geschmacks von Ibuprofon
CA2356310A1 (en) External preparations containing a basic drug
AU3990797A (en) Sustained release formulation
SE9101853D0 (sv) Improved tissue ashesive
EP0386960A3 (de) Pharmazeutische Zusammensetzungen zur Verwendung als Wirkstoffabgabevehikel und/oder als Wundverband
EP0558965A3 (de)
CA2174072A1 (en) Hydrogel-forming, self-solvating absorbable polyester block copolymers, and methods for use thereof
DE69627467D1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
CA2395846A1 (en) Diazepan derivatives or salts thereof
EP0992501A3 (de) Pyridoncarbonsäurederivate als antibakterielle Wirkstoffe
CA2160182A1 (en) Antimicrobial adhesive composition for dental uses
EP0796623A3 (de) Pharmazeutisches Präparat zur Behandlung von Blutgerinnungs-störungen
UA27748C2 (uk) Похідні піримідину, що мають активність антагоністів ангіотензину іі, спосіб їх отримання та фармацевтична композиція
ATE221054T1 (de) Substituierte oxazolyl-derivate zur behandlung von entzündungen
DE69730093D1 (de) Zubereitung mit verzögerter Freisetzung
EP0937468A3 (de) Klebstoffzusammensetzung für chirurgische Zwecke
DE69716586D1 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
WO2004060273A3 (en) Skin care composition containing an anionic polymer
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
AU4495793A (en) 2-aryl-5-(trifluoromethyl)-2-pyrroline compounds and process for the manufacture of insecticidal, 2-aryl-1-(alkoxymethyl)-4-halo-5-(trifluoromethyl) pyrroles
EP0806421A4 (de) Derivate der chinolincarbonsäure
CA2130762A1 (en) Treatment of Disease and Conditions Associated with Macrophage Infiltration
IE780217L (en) 1,3,5-triazine-2,6-dione derivatives
CA2385867A1 (en) Sustained release form comprising alpha-lipoic acid or derivatives thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0689841

Country of ref document: EP

REN Ceased due to non-payment of the annual fee